Milgrom SA, Koo J, Foreman N, Liu AK, Campbell K, Dorris K, Green AL, Dahl NA, Donson AM, Vibhakar R, Mulcahy Levy JM. Peri-transplant radiation therapy for young children treated with high-dose chemotherapy for primary brain tumors. Adv Rad Oncol (2022). Jul 7(4).
Madhavan K, Balakrishnan I, Chetty SL, Pierce A, Sanford B, Fosmire S, Elajaili H, Walker F, Wang D, Nozik-Grayck E, Mitra S, Dahl NA, Vibhakar R, Venkataraman S. Venetoclax cooperates with ionizing radiation to attenuate Diffuse Midline Glioma tumor growth. Clin Cancer Res (2022). Jun 1;28(11):2409-2424.
Dahl NA, Vibhakar R. Converging evidence for inhibition of transcriptional control in high-grade gliomas. Neuro Oncol. 2021 Aug 2;23(8):1225-1227. PubMed PMID: 33984150
Veo B, Danis E, Pierce A, Wang D, Fosmire S, Sullivan KD, Joshi M, Khanal S, Dahl N, Karam S, Serkova N, Venkataraman S, Vibhakar R. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in MYC-driven medulloblastoma. Cell Rep. 2021 Apr 27;35(4):109013. PubMed PMID: 33910002
Dahl NA, Donson AM, Sanford B, Wang D, Walker FM, Gilani A, Foreman NK, Tinkle CL, Baker SJ, Hoffman LM, Venkataraman S, Vibhakar R. NTRK Fusions Can Co-Occur With H3K27M Mutations and May Define Druggable Subclones Within Diffuse Midline Gliomas. J Neuropathol Exp Neurol. 2021 Mar 22;80(4):345-353. PubMed PMID: 33749791
Dahl NA, Vibhakar R. Converging evidence for inhibition of transcriptional control in high-grade gliomas. Neuro-Oncology (2021). Aug 2;23(8):1225-1227.
Dahl NA, Donson AM, Sanford B, Wang D, Walker FM, Gilani A, Foreman NK, Tinkle CL, Baker SJ, Hoffman LM, Venkataraman SV, Vibhakar R. NTRK fusions can co-occur with H3K27M mutations and may define druggable subclones within diffuse midline gliomas. J Neuropathol Exp Neurol (2021). 80(4): 345–353.
Dahl NA, Danis E, Balakrishnan I, Wang D, Pierce A, Walker FM, Gilani A, Serkova NJ, Madhavan K, Fosmire S, Green AL, Foreman NK, Venkataraman S, Vibhakar R. Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma. Cell Rep. 2020 Apr 7;31(1):107485. PubMed PMID: 32268092
Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R, Venkataraman S. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep. 2020 Oct 20;33(3):108286. PubMed PMID: 33086074
Dahl NA. Sacramentality in Palliation. J Clin Oncol. 2020 Aug 10;38(23):2695-2696. PubMed PMID: 32463738
Green A, Flannery PC, Hankinson TC, O’Neill B, Amani V, DeSisto J, Knox A, Lemma R, Hoffman L, Mulcahy Levy J, Raybin J, Hemenway M, Gilani A, Koschmann C, Dahl NA, Handler M, Pierce A, Venkataraman S, Foreman N, Vibhakar R, Wempe M, Dorris K. Preclinical and clinical investigation of intratumoral chemotherapy pharmacokinetics in DIPG. Neuro-Oncology Advances (2020) Volume 2, Issue 1, January-December 2020.
Balakrishnan I, Danis E, Pierce A, Madhavan K, Wang D, Dahl N, Sanford B, Birks DK, Davidson N, Metselaar DS, Meel MH, Lemma R, Donson A, Vijmasi T, Katagi H, Sola I, Fosmire S, Alimova I, Steiner J, Gilani A, Hulleman E, Serkova NJ, Hashizume R, Hawkins C, Carcaboso AM, Gupta N, Monje M, Jabado N, Jones K, Foreman N, Green A, Vibhakar R, Venkataraman S. Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG. Cell Rep. 2020 Oct 20;33(3):108286. PubMed PMID: 33086074
Dahl NA. Sacramentality in Palliation. J Clin Oncol. 2020 Aug 10;38(23):2695-2696. PubMed PMID: 32463738
Veo B, Danis E, Pierce A, Wang D, Fosmire S, Sullivan K, Joshi M, Khanal S, Dahl NA, Karam S, Serkova N, Venkataraman S, Vibhakar R. Transcriptional control of DNA repair networks by CDK7 regulates sensitivity to radiation in Myc-driven medulloblastoma.